- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0006247

About Maxmed Life Sciences Private Limited
Data last updated:
Maxmed Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC126912. Its GSTIN is 07AACCK4216H1ZS (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.5 Cr. It was formerly known as Kk Maxmed Private Limited. It is led by directors including Shubham Wasan and Sanjeev Wasan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No.12 Gang Dass Mohalla, Village – Aya Nagar New Delhi, Delhi, India – 110047.
As per the financials filed for FY 2023, the company reported a revenue of ₹66.13 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.24 Cr (net margin 1.9%) and EBITDA of ₹4.66 Cr (EBITDA margin 7.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Maxmed Lifesciences. As per MCA filings, the company has open charges of ₹33.35 Cr and satisfied charges of ₹1.62 Cr on record. Court records list 34 cases involving the company, including 22 filed by the company and 12 filed against it; 9 cases are pending. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹48 Lakh; the latest was in January 2016. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Hiral Labs Limited with revenue of ₹66.46 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers.
Maxmed Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0006247). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxmedlifesciences.com.
Company details
Recognitions & Rankings of Maxmed Life Sciences
Contact details
Maxmed Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is maxmedlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHouse No.12 Gang Dass Mohalla, Village – Aya Nagar New Delhi, Delhi, India – 110047
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxmed Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Maxmed Life Sciences operates one associated brand: Maxmed Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic solid and liquid dosage forms | maxmedlifesciences.com |
Business activity
The main business activity of Maxmed Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maxmed Life Sciences Private Limited, buy the company report.
Financials of Maxmed Life Sciences Private Limited
FY 2024 filings availableMaxmed Life Sciences Private Limited reported revenue of ₹66.13 Cr (down 10% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 10% fall in the latest year. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹66.13 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.66 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxmed Life Sciences Private Limited, buy the company report.
Board of directors of Maxmed Life Sciences Private Limited
Maxmed Life Sciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shubham Wasan | Director | 01 Jul 2019 | 7 Years 4 Months | Current |
| Vandana Wasan | Additional Director | 09 Nov 2024 | 2 Years 0 Months | Current |
| Sanjeev Wasan | Director | 14 Jun 2004 | 22 Years 5 Months | Current |
Peer comparison
Maxmed Life Sciences Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hiral Labs Limited | ₹66.46 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Skyec Drugs and Pharmaceuticals Private Limited | ₹66.27 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Medizen Labs Private Limited | ₹66.2 Cr (FY 2023) | 39.0% | Bangalore, Karnataka, India | |||
| Bestochem Formulations (India) Limited | ₹66.17 Cr (FY 2024) | 5.0% | New Delhi, Delhi, India | |||
| Maxmed Life Sciences Private Limitedthis company | ₹66.13 Cr (FY 2023) | ₹1.24 Cr | 1.9% | -10.0% | 40 | Delhi, India |
| Skymap Healthcare Private Limited | ₹65.96 Cr (FY 2022) | 70.0% | New Delhi, Delhi, India | |||
| Caplet India Pvt.Ltd. | ₹65.86 Cr (FY 2025) | -5.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Maxmed Life Sciences Private Limited, buy the company report.
Auditor
Maxmed Life Sciences Private Limited is audited by ASHOK SHYAM & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHOK SHYAM & ASSOCIATES | FY 2023 | 011223N |
Shareholding
The shareholding of Maxmed Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxmed Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2025 | 101189775 | Hdfc Bank Limited | ₹7.95 Cr | Open | |
| 05 Jan 2024 | 100871878 | Others | ₹10.5 Cr | Open | |
| 25 May 2023 | 100755713 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 30 Sep 2019 | 100293862 | Others | ₹5 Cr | Open | |
| 14 Feb 2015 | 10552298 | Hdfc Bank Limited | ₹5.95 Cr | Open |
To see the full charge records of Maxmed Life Sciences Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Maxmed Life Sciences Private Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹48 Lakh; the latest was in January 2016.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2016 | Rights issue | ₹2 Cr | Investors: 2 individuals |
| Mar 2009 | Funding round | ₹35 Lakh | Investors: 2 individuals |
| Mar 2007 | Funding round | ₹13 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maxmed Life Sciences Private Limited has 34 court cases on record: 22 filed by Maxmed Life Sciences, 12 filed against it. 9 cases are pending and 25 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 30 | 11 | 8 |
| High courts | 4 | 1 | 1 |
Cases on record (5 of 34)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against M/S Delius Pharmaceuticals Private Limited | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Glendale Biomed Private Limited and Addl Director Suraj Prakash Singh and Coo Prakash Shankar | Pending |
| High Court | Writ petition | Filed by the company against Kerala Medical Services Corporation Limited and 1 other | Pending |
| District court, South West, Delhi | Criminal case | Filed by the company against M/S.Futurelife Pharmaceuticals Pvt.Ltd. and 2 others | Disposed |
| High Court | Writ petition | Filed by the company against Kerala Medical Service Corporation Limited and 1 other | Disposed |
To see the full case history of Maxmed Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Maxmed Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Biochem Laboratries Rudrapur | |||
| an individual supplier | |||
| Amba Sales & Services Amhedabad-382445 | |||
| an individual supplier | |||
| L&P Sterile Packaging Private Limited |
To see the full MSME payment records of Maxmed Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Maxmed Life Sciences Private Limited has a workforce of 40 employees on its EPFO records as of Apr 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 40 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Maxmed Life Sciences Private Limited, buy the company report.
GST
Maxmed Life Sciences has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCK4216H1ZS | Delhi | Active | 01 Jul 2017 |
| 05AACCK4216H1ZW | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxmed Life Sciences Private Limited, buy the company report.
Recent activity
Maxmed Life Sciences Private Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Vandana Wasan ceased to be Additional Director on 13 May 2025.
10 earlier events are in the company report.
Frequently asked questions
Maxmed Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2004 (22+ years old) and is registered under CIN U24232DL2004PTC126912.
Maxmed Life Sciences has 3 current directors:
- Shubham Wasan - Director
- Vandana Wasan - Additional Director
- Sanjeev Wasan - Director
The latest financial statements of Maxmed Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxmed Life Sciences is 07AACCK4216H1ZS, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 05AACCK4216H1ZW (Uttarakhand).
The CIN (Corporate Identification Number) of Maxmed Life Sciences is U24232DL2004PTC126912. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxmed Life Sciences has 34 court cases on record: 22 filed by the company and 12 filed against it. 9 are pending. Most are in the district courts.
Maxmed Life Sciences was incorporated on 14 June 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Maxmed Life Sciences has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹48 Lakh; the latest was in January 2016.
The peers of Maxmed Life Sciences by revenue are Hiral Labs Limited, Skyec Drugs and Pharmaceuticals Private Limited, Medizen Labs Private Limited, Bestochem Formulations (India) Limited, Skymap Healthcare Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vandana Wasan ceased to be Additional Director on 13 May 2025. Vandana Wasan was appointed as Additional Director on 09 Nov 2024. Shubham Wasan ceased to be Additional Director on 31 Oct 2024. Maxmed Life Sciences has 7 board changes on record in total.
Yes, Maxmed Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-11-0006247).
Maxmed Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 5 overdue payments to 5 micro and small suppliers. The latest return was filed on 08 Jun 2019.

